Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03170583 · ClinicalTrials.gov registry record
SJM Brady MRI Post Approval Study
A clinical trial, sponsored by Abbott Medical Devices.
- Terminated
- Registry status
- 1,768
- Enrollment target
NCT03170583 is a clinical trial that was terminated before completion, run by Abbott Medical Devices. The registered enrollment target is 1,768 participants.
The verdict
NCT03170583 was terminated before completion, sponsored by Abbott Medical Devices.
- TERMINATED
- Registry status
- 1,768 participants
- Enrollment target
Study Summary
The purpose of this post approval study is to evaluate the long-term safety of the FDA approved St. Jude Medical Tendril MRI™ lead implanted with a SJM Brady MRI implantable pulse generator (IPG) such as the Accent MRI™, Assurity MRI™, Endurity MRI™ pacemaker, or similar model (SJM Brady MRI System) in subjects with a standard bradycardia pacing indication.
Interventions
- DEVICE St. Jude Medical Tendril MRI™ lead
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,768 participants |
| Start Date | 2017-06-08 |
| Est. Completion | 2020-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03170583
The ClinicalTrials.gov registry entry for NCT03170583 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1,768 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which St. Jude Medical Tendril MRI™ lead is the first listed.
NCT03170583 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03170583 about?
NCT03170583 is a clinical study titled "SJM Brady MRI Post Approval Study". The purpose of this post approval study is to evaluate the long-term safety of the FDA approved St. Jude Medical Tendril MRI™ lead implanted with a SJM Brady MRI implantable pulse generator (IPG) such as the Accent MRI™, Assurity MRI™, Endurity MRI™ pacemaker, or similar model (SJM Brady MRI System)...
What is the current status of trial NCT03170583?
This trial is currently terminated. The enrollment target is 1,768 participants. The study started on 2017-06-08. Estimated completion is 2020-06-30.
What interventions are being tested in trial NCT03170583?
The interventions under investigation include: St. Jude Medical Tendril MRI™ lead (DEVICE).
Who is sponsoring clinical trial NCT03170583?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.